Evaluates tumor-host interactions in non-small cell lung cancer, suggesting new prognostic methods.
The tumor invasive front is a critical interface for tumor-host interactions that impacts patient prognosis. Although the tumor-node-metastasis (TNM) staging system and single-parameter assessments such as tumor budding, T-cell density, tertiary lymphoid structures (TLS), and stromal features provide important prognostic information, they capture only partial aspects of this spatially organized tumor-host interface. Inspired by the traditional Chinese medicine concept of “Huchang”, used here as a metaphorical descriptor of host-protective organization at the tumor boundary, and informed by recent advances in spatial immunology, we propose the Huchang-Barrier (HB) framework. HB conceptualizes the invasive front as a dynamic tumor-host interface whose biological state is determined by the balance between tumor invasive burden and host physical/tissue and spatial immune barriers. Unlike fixed single-marker scores or tumor-type-specific microenvironmental indices, HB integrates three conserved functional elements while allowing cancer-adapted readouts, thereby providing a modular framework for evaluating the invasion-barrier balance at the invasive front. To improve operability, we outline a two-tier assessment strategy and provide a minimal executable HB-Standard example in resected non-small cell lung cancer (NSCLC). The HB framework is proposed as a hypothesis-generating spatial pathology model that requires retrospective calibration, independent validation, and prospective testing before clinical implementation.
No takes yet. Share an insight, caveat, or question.
Xie et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: